Certain breast cancer treatments can increase your risk of developing other types of cancer, including:
-
salivary gland cancer
-
lung cancer
-
esophageal cancer
-
stomach cancer
-
colon cancer
-
uterine cancer
-
ovarian cancer
-
thyroid cancer
-
connective tissue and bone cancer (sarcoma)
-
skin cancer (melanoma)
-
acute myeloid leukemia (a type of blood and bone marrow cancer)
Based on the treatments you’ve received, you and your doctor develop a screening plan for other cancers that makes sense for you. For example, after you complete your main breast cancer treatment, your doctor may recommend you have tests such as MRIs or ultrasounds to closely monitor for recurrence. Your doctor also may recommend tests for long-term side effects.
Some of the most commonly recommended tests for breast cancer survivors are listed below.
It’s important that everyone continue doing monthly breast self-exams (BSEs) to examine their breasts or skin and chest wall for any new masses or unusual growths once they’ve healed after:
-
mastectomy or lumpectomy
-
breast reconstruction surgery
-
going flat
Scar tissue from surgery can make breast self-exams challenging at first. It can be difficult to tell the difference between normal scar tissue and a bump or growth. As the tissue heals, it should get easier, but talk to your healthcare team about any concerns you may have.
Learn more
Breast Self-Exam (BSE)
If you’ve had lumpectomy or mastectomy for breast cancer or breast reconstruction surgery, you probably don’t have the same mammogram screening recommendations as someone with no history of breast cancer.
Learn more
Mammograms After Different Types of Breast Surgery
Tamoxifen or Fareston (chemical name: toremifene) — treatments for hormone receptor-positive breast cancer — can increase the risk of uterine and endometrial cancer. If you take either tamoxifen or Fareston and still have your uterus, it’s important to have a pelvic exam at least once every year. The risk is highest in post-menopausal women.
Learn more
Endometrial Cancer
Certain breast cancer treatments, including aromatase inhibitors, can contribute to bone loss and put you at higher risk of breaking a bone. The most common bone density test is a DEXA scan. If you’re currently taking an aromatase inhibitor, you can expect to have a bone density test at least every two years.
Learn more
Osteoporosis and Osteopenia
To assess your heart health, doctors measure your:
-
blood pressure
-
cholesterol levels, including LDL (low-density lipoprotein), HDL (high-density lipoprotein), and triglycerides
-
blood glucose levels
-
body mass index (BMI), a weight-to-height ratio
Learn more
Heart Problems
Doctors recommend screening for colorectal cancer with a colonoscopy starting at age 45.
Men who’ve been diagnosed with breast cancer have a higher risk of developing prostate cancer, even if they don’t have a BRCA1 or BRCA2 genetic mutation. It’s important to ask your doctor how frequently you should have a prostate-specific antigen (PSA) blood test. It’s also important for transgender women and nonbinary people assigned male at birth who are diagnosed with breast cancer and who have prostate glands to speak with their doctors about prostate cancer screening.
Written by: Kris Conner, contributing writer, and Jamie DePolo, senior editor
"breast" - Google News
September 27, 2022 at 03:58AM
https://ift.tt/nAalptw
Breast Cancer Survivorship Screening & Testing - Breastcancer.org
"breast" - Google News
https://ift.tt/epnNdOx
https://ift.tt/yf1ndI0
Bagikan Berita Ini
0 Response to "Breast Cancer Survivorship Screening & Testing - Breastcancer.org"
Post a Comment